Psychiatric disorders, acne and systemic retinoids: comparison of risks

References

• Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129:2136–2141.
   PubMed Web of Science ®Google Scholar
• Dunn LK, O’Neill JL, Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011;17:1.
   PubMedGoogle Scholar
• Halvorsen JA, Stern RS, Dalgard F, et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131:363–370.
   PubMed Web of Science ®Google Scholar
• Bhate K, Williams HC. What’s new in acne? An analysis of systematic reviews published in 2011-2012. Clin Exp Dermatol. 2014;39:273-277; quiz 277-278.
   PubMed Web of Science ®Google Scholar
• Yang Y-C, Tu H-P, Hong C-H, et al. Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study. Biomed Res Int. 2014;2014:504279.
   PubMedGoogle Scholar
• Recommandations de bonne pratique traitement de l’acné par voie locale et générale recommandations. [ cited 2017 Jan 26]. Available from: -http://www.sfdermato.org/media/pdf/recommandation/label-recommandations-acne-post-college-54ac60356d1b9584a71ccaac92cf3724.pdf
   Google Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945–973.e33.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Harris VR. Modern management of acne. Med J Aust. 2017;206:41–45.
   PubMed Web of Science ®Google Scholar
• Meyskens F. Short clinical reports: serum lipid changes during etretinate therapy. J Am Acad Dermatol. 1982;6:732–734.
   PubMedGoogle Scholar
• Lindemayr H. Isotretinoin intoxication in attempted suicide. Acta Derm Venereol. 1986;66:452–453.
   PubMed Web of Science ®Google Scholar
• Burket JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol. 1987;123:432–433.
   PubMedGoogle Scholar
• Hepburn NC. Deliberate self-poisoning with isotretinoin. Br J Dermatol. 1990;122:840–841.
   PubMed Web of Science ®Google Scholar
• Mahr G. Isotretinoin and trichotillomania. Psychosomatics. 1990;31:235.
   PubMed Web of Science ®Google Scholar
• Gatti S, Serri F. Acute depression from isotretinoin. J Am Acad Dermatol. 1991;25:132.
   PubMed Web of Science ®Google Scholar
• Halter U. [A case from practice (224). Acute exogenous reaction type (delirium) following administration of Tigason]. Schweiz Rundsch Für Med Prax Rev Suisse Médecine Prax. 1991;80:883–884.
   PubMedGoogle Scholar
• Bravard P, Krug M, Rzeznick J. Isotretinoine et depression: soyons vigilants. Nouv Dermatol. 1993;12:215.
   Web of Science ®Google Scholar
• Aubin S, Lorette G, Muller C, et al. Massive isotretinoin intoxication. Clin Exp Dermatol. 1995;20:348–350.
   PubMed Web of Science ®Google Scholar
• Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137:246–250.
   PubMed Web of Science ®Google Scholar
• Kovacs SO, Mallory SB. Mood changes associated with isotretinoin and substance abuse. Pediatr Dermatol. 1996;13:350.
   PubMed Web of Science ®Google Scholar
• Byrne A, Hnatko G. Depression associated with isotretinoin therapy. Can J Psychiatry Rev Can Psychiatr. 1995;40:567.
   PubMed Web of Science ®Google Scholar
• Cott AD, Wisner KL. Isotretinoin treatment of a woman with bipolar disorder. J Clin Psychiatry. 1999;60:407–408.
   PubMed Web of Science ®Google Scholar
• Ng CH, Tam MM, Hook SJ. Acne, isotretinoin treatment and acute depression. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2001;2:159–161.
   PubMedGoogle Scholar
• Erkolahti R, Ilonen T, Eerola M, et al. Body dysmorphic disorder of twins with facial illness after successful isotretinoin therapy. Acta Derm Venereol. 2004;84:499–500.
   PubMed Web of Science ®Google Scholar
• Shehi GM, Bryson WJ. Hypersomnia associated with isotretinoin in a patient with recurrent major depressive disorder and acne vulgaris. Sleep. 2004;27:821.
   PubMed Web of Science ®Google Scholar
• La Placa M. Acute depression from isotretinoin. Another case. J Eur Acad Dermatol Venereol JEADV. 2005;19:387.
   PubMed Web of Science ®Google Scholar
• Barak Y, Wohl Y, Greenberg Y, et al. Affective psychosis following accutane (isotretinoin) treatment. Int Clin Psychopharmacol. 2005;20:39–41.
   PubMed Web of Science ®Google Scholar
• Poblete AC, M V H, Eva CP. [Panic attacks in a patient treated with isotretinoin for acne. Report of one case]. Rev Médica Chile. 2006;134:1565–1567.
   PubMed Web of Science ®Google Scholar
• Bachmann C, Grabarkiewicz J, Theisen FM, et al. Isotretinoin, depression and suicide ideation in an adolescent boy. Pharmacopsychiatry. 2007;40:128.
   PubMed Web of Science ®Google Scholar
• Danby FW. Oral isotretinoin, neuropathy and hypovitaminosis A. Clin Exp Dermatol. 2009;34:e260.
   PubMed Web of Science ®Google Scholar
• Smedje H, Schwan S, Hallberg E, et al. Onset of Kleine-Levin syndrome in association with isotretinoin treatment. Acta Paediatr Oslo Nor. 2010;99:946–948.
   PubMed Web of Science ®Google Scholar
• Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, et al. Genetic vulnerability and isotretinoin-induced psychiatric adverse events. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2010;11:158–159.
   PubMed Web of Science ®Google Scholar
• Ballester Sánchez R, de Unamuno Bustos B, Agustí Mejías A, et al. [Increase in creatine phosphokinase and a suicide attempt during isotretinoin treatment]. An Pediatría Barc Spain. 2012;76:365–366.
   PubMed Web of Science ®Google Scholar
• Alcalá Partera JA. [Depression and panic attack in acne treated with isotretinoin]. Semergen Soc Esp Med Rural Generalista. 2012;38:188–191.
   Google Scholar
• Ersoy MA, Ersoy HT. Manic symptoms associated with isotretinoin and methylphenidate combination: a case report. Klin Psikofarmakol Bül Bull Clin Psychopharmacol. 2014;24:261–264.
   Web of Science ®Google Scholar
• Rajagopal S. Acute psychosis induced by isotretinoin. Indian J Psychiatry. 2014;56:295–297.
   PubMed Web of Science ®Google Scholar
• Ferahbas A, Turan MT, Esel E, et al. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatol Treat. 2004;15:153–157.
   PubMedGoogle Scholar
• McGrath EJ, Lovell CR, Gillison F, et al. A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms. Br J Dermatol. 2010;163:1323–1329.
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol. 1987;17:25–32.
   PubMed Web of Science ®Google Scholar
• YesIlova Y, Bez Y, ArI M, et al. Effects of isotretinoin on obsessive compulsive symptoms, depression, and anxiety in patients with acne vulgaris. J Dermatol Treat. 2012;23:268–271.
   PubMed Web of Science ®Google Scholar
• Chia CY, Lane W, Chibnall J, et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol. 2005;141:557–560.
   PubMed Web of Science ®Google Scholar
• Marron SE, Tomas-Aragones L, Boira S. Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. Acta Derm Venereol. 2013;93:701–706.
   PubMed Web of Science ®Google Scholar
• Azoulay L, Blais L, Koren G, et al. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry. 2008;69:526–532.
   PubMed Web of Science ®Google Scholar
• Hersom K, Neary MP, Levaux HP, et al. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol. 2003;49:424–432.
   PubMed Web of Science ®Google Scholar
• Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000;136:1231–1236.
   PubMedGoogle Scholar
• Sundström A, Alfredsson L, Sjölin-Forsberg G, et al. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. Bmj. 2010;341:c5812.
   PubMed Web of Science ®Google Scholar
• Friedman T, Wohl Y, Knobler HY, et al. Increased use of mental health services related to isotretinoin treatment: a 5-year analysis. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2006;16:413–416.
   PubMed Web of Science ®Google Scholar
• Bremner JD, Shearer KD, McCaffery PJ. Retinoic acid and affective disorders: the evidence for an association. J Clin Psychiatry. 2012;73:37–50.
   PubMed Web of Science ®Google Scholar
• Montastruc J-L, Sommet A, Lacroix I, et al. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Jt Bone Spine Rev Rhum. 2006;73:629–32.
   PubMed Web of Science ®Google Scholar
• LOI n° 2011-2012 du 29 décembre 2011 relative au renforcement de la sécurité sanitaire du médicament et des produits de santé. Available from: https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000025053440&categorieLien=id.
   Google Scholar
• Arrêté du 10 juin 2011 pris pour l’application des articles R. 5121-154, R. 5121-167 et R. 5121-179 du code de la santé publique et relatif aux modalités de signalement des effets indésirables par les patients et les associations agréées de patients |Legifrance [WWW Document]. [ cited 2017 May 25]. Available from: https://www.legifrance.gouv.fr/eli/arrete/2011/6/10/ETSP1108636A/jo
   Google Scholar
• Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20:109–117.
   PubMed Web of Science ®Google Scholar
• van Riemsdijk MM, Sturkenboom MCJM, Pepplinkhuizen L, et al. Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands. J Clin Psychiatry. 2005;66:199–204.
   PubMed Web of Science ®Google Scholar
• Résumé des Caractéristiques du Produit [WWW Document]. [ cited 2016 Oct 14]. Available from: http://agence-prd.ansm.sante.fr/php/ecodex/rcp/R0186807.htm
   Google Scholar
• Lafay-Chebassier C, Chavant F, Favrelière S, et al. Drug-induced depression: a case/non case study in the French pharmacovigilance database. Therapie. 2015;70:425–432. DOI:10.2515/therapie/2015026
   PubMed Web of Science ®Google Scholar
• Beau-Salinas F, Jonville-Béra AP, Cissoko H, et al. Drug dependence associated with triptans and ergot derivatives: a case/non-case study. Eur J Clin Pharmacol. 2010;66:413–417.
   PubMed Web of Science ®Google Scholar
• de Boer A. When to publish measures of disproportionality derived from spontaneous reporting databases? Br J Clin Pharmacol. 2011;72:909–911.
   PubMed Web of Science ®Google Scholar
• Faillie J-L, Babai S, Crépin S, et al. Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French pharmacovigilance database. Acta Diabetol. 2014;51:491–497.
   PubMed Web of Science ®Google Scholar
• Moore N, Kreft-Jais C, Haramburu F, et al. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol. 1997;44:513–518.
   PubMed Web of Science ®Google Scholar
• Moulis G, Béné J, Sommet A, et al. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database. Lupus. 2012;21:885–889.
   PubMed Web of Science ®Google Scholar
• Cortesi PA, Scalone L, Belisari A, et al. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis. 2014;70:158–168.
   PubMed Web of Science ®Google Scholar
• Kirby B, Richards HL, Woo P, et al. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol. 2001;45:72–76.
   PubMed Web of Science ®Google Scholar
• Sampogna F, Sera F, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol. 2004;122:602–607.
   PubMed Web of Science ®Google Scholar
• Misery L, Wolkenstein P, Amici J-M, et al. Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based study. Acta Derm Venereol. 2014. DOI:10.2340/00015555-1998.
   PubMed Web of Science ®Google Scholar
• de Boissieu P, Kanagaratnam L, Abou Taam M, et al. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2014;23:989–992.
   PubMed Web of Science ®Google Scholar
• Bumb JM, Solojenkina X, Zink M. Schizophreniform psychosis during treatment with alitretinoin. J Clin Psychopharmacol. 2015;35:612.
   PubMed Web of Science ®Google Scholar
• CR_CT_Pharmacovigilance_CT012016053_14-06-2016.pdf. [ cited 2017 Jan 26]. Available from: http://ansm.sante.fr/content/download/98237/1247569/version/1/file/CR_CT_Pharmacovigilance_CT012016053_14-06-2016.pdf
   Google Scholar
• TOCTINO_RI2014_Avis 2_CT13649 - CT-13649_TOCTINO_RI2014_Avis 2_CT13649.pdf. [ cited 2017 Jan 26]. Available from: http://www.has-sante.fr/portail/upload/docs/evamed/CT-13649_TOCTINO_RI2014_Avis%202_CT13649.pdf
   Google Scholar
• Rohrback JM, Fleischer AB, Krowchuk DP, et al. Depression is not common in isotretinoin-treated acne patients. J Dermatol Treat. 2004;15:252.
   PubMedGoogle Scholar
• Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med. 2001;344:460.
   PubMed Web of Science ®Google Scholar
• Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol. 2001;45:515–519.
   PubMed Web of Science ®Google Scholar
• Australian adverse drug reactions advisory committee. Acne, isotretinoin and suicidality. Australian adverse drug reactions bulletin. 2005 june;24(3):10.
   Google Scholar
• Australian Adverse Drug Reactions Bulletin – Depression with isotretinoin (Health Collection) - Informit [WWW Document]. [ cited 2015 Jan 26]. Available from: http://search.informit.com.au/documentSummary;dn=564846558525230;res=IELHEA
   Google Scholar
• Wray CM.Isotretinoine: depression. Canadian Averse Drug Reaction Newsletter. 1999;9:1.
   Google Scholar
• Bremner JD, McCaffery P. The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:315–331.
   PubMed Web of Science ®Google Scholar
• Bremner JD, Fani N, Ashraf A, et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry. 2005;162:983–991.
   PubMed Web of Science ®Google Scholar
• O’Reilly KC, Shumake J, Gonzalez-Lima F, et al. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology. 2006;31:1919–1927.
   PubMed Web of Science ®Google Scholar
• Serafini G, Hayley S, Pompili M, et al. Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets? CNS Neurol Disord Drug Targets. 2014;13:1708–1721.
   PubMed Web of Science ®Google Scholar
• Cai L, Yan X-B, Chen X-N, et al. Chronic all-trans retinoic acid administration induced hyperactivity of HPA axis and behavioral changes in young rats. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2010;20:839–847.
   PubMed Web of Science ®Google Scholar
• Becking K, Spijker AT, Hoencamp E, et al. Disturbances in hypothalamic-pituitary-adrenal axis and immunological activity differentiating between unipolar and bipolar depressive episodes. PLoS One. 2015;10:e0133898.
   PubMed Web of Science ®Google Scholar
• Wysowski DK, Swartz L. Relationship between headache and depression in users of isotretinoin. Arch Dermatol. 2005;141:640–641.
   PubMedGoogle Scholar
• Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385–396.
   PubMed Web of Science ®Google Scholar
• Thériaque [WWW Document]. [ cited 2017 May 22]. Available from: http://www.theriaque.org/apps/recherche/rch_simple.php#
   Google Scholar